Patent Agent
Audrey Chang, Ph.D., a qualified European patent attorney and a U.S. patent agent, focuses on strategic patent portfolio development and client counseling in the biotechnology and pharmaceutical fields. She applies her technical expertise in life sciences to support a broad range of patent-related matters.
Audrey assists clients with developing intellectual property (IP) protection strategies and manages global patent prosecution portfolios. She conducts patent due diligence and provides opinions on freedom-to-operate (FTO), patentability, infringement, and validity.
Audrey has worked in a variety of IP departments in both Europe and the U.S. Prior to joining Finnegan, she worked at a Belgium-based biopharma company specializing in neurological and autoimmune conditions. She handled IP strategy, patent drafting and prosecution, and FTO analyses in support of early-stage products in gene therapy and antibody therapeutics. Audrey gained experience in patent strategy and prosecution through working at a 3D printing company and a university technology transfer office, both in Belgium, as well as at a general practice law firm in Boston, Massachusetts.
Audrey’s scientific training as a doctoral student at the Massachusetts Institute of Technology (MIT) focused on the molecular mechanisms underlying synaptic plasticity.
Global prosecution and portfolio management for major pharmaceutical company
Finnegan is lead and preferred IP strategy counsel for one of the largest pharmaceutical companies in the world, handling all aspects of prosecution and portfolio management for multiple top-tier products for the client. The work spans the gamut from drafting and prosecution through larger strategic planning, patent term extension, and pre-litigation preparation on blockbuster small molecule and biologic products in the oncology, rheumatology, immunology, neuromuscular, and cell and gene therapy spaces.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.